← Back to headlines
Summit Therapeutics Ends 2025 with Strong Financials
Summit Therapeutics concluded 2025 with robust cash reserves and increased investment in its clinical development programs.
3 Mar, 07:21 — 3 Mar, 07:21
Sources
Showing 1 of 1 sources
Related Stories
Volkswagen Board Approves Restructuring Plan to Cut 100,000 Jobs by 2030
32m ago
Trump Administration Asks Supreme Court to Lift Block on Mail Ballot Restrictions
40m ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
2h ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
2h ago